Baxter International Inc.

NYSE:BAX

46.68

-0.33 (-0.70%)

7:56:48 PM EDT: $46.65 -0.03 (-0.06%)

Market Cap (Intraday)	23.37B
Current PE	N/A
Forward PE	13.08
2yr Forward PE	13.15

See more stats

Estimates Current Quarter

Revenue	$3.76 Billion
Adjusted EPS	$0.95

See more estimates

10-Day MA	$46.08
50-Day MA	$49.53
200-Day MA	$58.89

See more pivots

Baxter International Inc. Stock, NYSE:BAX

One Baxter Parkway, Deerfield, Illinois 60015-4625

United States of America

Phone: +1.224.948.2000

Number of Employees: 60000

http://www.baxter.com

Description

Baxter International, Inc. engages in the provision of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies, premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software, and services. It operates through the following segment: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.